Thus, as is apparent below, studies of the effects of stress on P

Thus, as is apparent below, studies of the effects of stress on PFC in rodent have focused on mPFC. While the PFC is highly evolved in NHPs and humans and mediates particularly complex cognitive processes, it is also highly vulnerable. The PFC has been implicated in multiple brain disorders such as attention deficit disorder, schizophrenia, depression, and

PTSD (Arnsten, 2009a, Drevets et al., 1997b, Gamo and Arnsten, 2011 and Tan et al., 2007), and it is also vulnerable to stress (McEwen and Gianaros, 2011) and normal aging (Morrison and Baxter, 2012), as well as Alzheimer’s disease (Hof and Morrison, 2004 and Morrison and Hof, 1997) in humans. The PFC has also been identified as a cortical AT13387 order region that is

affected by decreased estrogen levels in women (Shanmugan and Epperson, 2012). Monkey studies have highlighted buy Alectinib the vulnerability of dorsolateral PFC (dlPFC) to stress (Arnsten, 2009b), aging (Morrison and Baxter, 2012 and Wang et al., 2011), and estrogen depletion (Hao et al., 2006, Hao et al., 2007 and Rapp et al., 2003). As will be discussed in detail in this Review, the homologous mPFC is highly vulnerable to stress (Cook and Wellman, 2004, Holmes and Wellman, 2009 and Radley et al., 2004), aging (Bloss et al., 2011), and estrogen depletion (Shansky et al., 2010) in rats. Thus, while PFC clearly is an important target for intervention regarding multiple devastating brain disorders in humans, the animal models faithfully reflect several of its vulnerabilities and can thus provide important mechanistic insights into the unique enough capacities and vulnerabilities of this neocortical region that plays such a crucial role in higher cognitive processes. The mPFC has extensive downstream projections to regions as diverse as the amygdala and the brainstem (Sesack et al., 1989), providing a substrate for downstream regulation of autonomic and neuroendocrine balance (Thayer and

Brosschot, 2005), with influences on parasympathetic (Thayer and Sternberg, 2006) and hypothalamo-pituitary adrenal (HPA) activity (Diorio et al., 1993). For HPA activity and autonomic control in rat, dorsal and ventral mPFC have different effects, based on experiments showing that lesions to the dorsal mPFC enhanced restraint stress-induced c-Fos and corticotropin-releasing factor (CRF) mRNA expression in the neurosecretory region of the paraventricular hypothalamus (PVH), whereas ablation of the ventral mPFC decreased stress-induced c-Fos protein and CRF mRNA expression in this compartment but increased c-Fos induction in PVH regions involved in central autonomic control (Radley et al., 2006).

Posted in Uncategorized | Leave a comment

, 2009, Clopath et al , 2008, Frey, 2001, Frey and Morris, 1997 a

, 2009, Clopath et al., 2008, Frey, 2001, Frey and Morris, 1997 and Okada et al., 2009). This, in turn, buy LY294002 would lead to a memory engram being formed, at the single-cell level, at synapses dispersed throughout the dendritic arbor. However, an alternative model combining STC with the phenomenon of local activity-induced protein synthesis (Martin and Kosik, 2002 and Steward and Schuman, 2001), namely the Clustered Plasticity Hypothesis (CPH) (Govindarajan et al., 2006), predicts that STC is biased toward

occurring between spines that are close together. This would result in memory engrams being preferentially formed at synapses clustered within dendritic compartments, such as a branch (Govindarajan et al., 2006). Competition

among synapses for limiting PrPs would further restrict the engram to such a dendritic compartment because spines close to the site of translation would use up limiting PrPs and reduce their concentration at more distant spines (Govindarajan et al., 2006). The advantages of the CPH include increased efficiency of long-term memory formation and retrieval, as well as a greater capacity for memory storage for an individual neuron (Govindarajan et al., 2006). A study of the link between the level of E-LTP at a given spine and the strength of its synaptic tag, the spatial limits over which STC can occur, and selleck the temporal dynamics of the STC at individual stimulated competing spines require ADP ribosylation factor a

method that permits stimulations and response monitoring of single spines. However, the field stimulation and field recording methods that have been used in the past to study STC measure the average response of a population of unidentified stimulated synapses. Thus, we developed a method using two-photon glutamate uncaging at single spines on proximal apical dendritic branches of CA1 pyramidal neurons to examine the relationship between spines that participate in STC. The expression of L-LTP was assayed by examining spine volume using two-photon imaging of the fluorescent protein Dendra (Gurskaya et al., 2006), along with perforated patch-clamp electrophysiology in some experiments to measure the change in the postsynaptic response to the uncaging of glutamate. We found that STC is temporally asymmetric, is spatially localized, and is biased toward occurring between stimulated spines that reside on the same dendritic branch. In addition, while strongly stimulated spines facilitate induction of L-LTP at neighboring weakly stimulated spines, the stimulated spines then compete for expression of L-LTP. Lastly, we demonstrated that there is a bias toward L-LTP being induced at a single dendritic branch, as opposed to across branches.

Posted in Uncategorized | Leave a comment

Consistent with the first possibility, the authors found that inj

Consistent with the first possibility, the authors found that injection of antisense of ApNRX into SNs or antisense of ApNLG into MNs indeed significantly reduced the increase in varicosities observed at 24 hr after repeated 5HT. They next examined the second possibility by expressing in SNs an

ApNRX mutant that lacks the cytoplasmic tail. This mutant competes with endogenous ApNRX for ApNLG binding but is not capable of binding to intracellular signaling partners for recruiting synaptic vesicles (Dean and Dresbach, 2006). Overexpression of the mutant significantly reduced 24 hr LTF induced by 5-HT. In parallel with these experiments, the authors compared the distribution of ApNRX before and 24 hr after repeated 5-HT. They found an enrichment of ApNRX in newly formed varicosities as well as filling of pre-existing empty varicosities with ApNRX after 5-HT application. These data are consistent

with the previous findings that enrichment of synaptic XAV-939 clinical trial vesicles occurs in both newly formed and pre-existing varicosities after 5-HT (Kim et al., 2003). Taken together, these results suggest that ApNRX-ApNLG signaling contributes to LTF by activating pre-existing “silent” synapses, as well as by increasing the formation of newly functional synapses, thus coupling functional and structural synaptic plasticity. Synaptic facilitation induced by repeated 5-HT can last at least 72 hr, and synaptic growth is thought to play a predominant role in this late (48–72 hr) phase of LTF (Casadio et al., 1999). Since ApNRX and ApNLG are important for synaptic growth, the authors further examined their contribution to the persistence of LTF. For these experiments, antisense of ApNRX or ApNLG was injected into SNs or MNs, respectively, at 24 hr after repeated 5-HT application. Either of these treatments induced a significant decay of LTF at 48 hr

after 5-HT, which further decayed to near baseline at 72 hr. Thus, transsynaptic neurexin-neuroligin signaling is critical for the maintenance of persistent LTF. Recent advances in a series of genetic analyses of neurological to diseases have revealed a link between impaired neurexin-neuroligin signaling and autism (Pardo and Eberhart, 2007). For example, an Arginine to Cysteine (R451C) mutation in neuroligin-3, which reduces its surface expression and binding to neurexins, has been observed in autistic siblings (Jamain et al., 2003). Moreover, transgenic mice with the same mutation show increased inhibitory transmission but no change in basal excitatory transmission (Südhof, 2008). In the present paper, the authors explore the physiological consequences of the homologous mutation in ApNLG. They report that expression of this mutant in MNs significantly reduced 1 hr ITF and 24 hr LTF after repeated 5-HT. Interestingly, autistic patients carrying this mutation also exhibit learning deficits (Jamain et al., 2003).

Posted in Uncategorized | Leave a comment

, 1991 and Park et al , 2008) The optic nerve differs from other

, 1991 and Park et al., 2008). The optic nerve differs from other CNS areas in several respects, however. First, it is a pure axonal tract (no gray matter). Second, in distinction to most spinal axons, the vast majority (>99%) of retinal ganglion cells die after optic nerve transection, a far greater proportion than the number of degenerating neuronal cell bodies that give rise to axons traversing a spinal cord lesion site. This raises the possibility that a unique biological feature of a subset of surviving retinal ganglion axons is the actual subject of study. The simplicity of the

optic projection to thalamic and collicular targets is a virtue: the nerve consists essentially of a single projection to few targets. If an optic nerve lesion is complete, then there is little question that regeneration has occurred. However, its simplicity is also a drawback: the optic nerve model poorly replicates MK-1775 selleck products the diverse and complex nature of a spinal cord injury, which by virtue of containing both gray and white matter results in hemorrhagic necrosis, extensive inflammation, and secondary cell death and cavitation. Moreover, the complex circuitry of the spinal cord presents a diversity of inappropriate targets through which growing axons must hypothetically navigate before restoring useful function. Thus, the primary strength of the optic nerve model may

lie in understanding fundamental mechanisms underlying axonal degeneration and regeneration, leading to the identification of targets that can then be tested in models of SCI (Kurimoto et al., 2010 and Park et al., 2008). The model is discussed Histone demethylase in more detail in other reviews (Benowitz and Yin, 2008 and Maclaren and Taylor, 1997). Studies of peripheral nerve injury have been invaluable in identifying neural mechanisms that underlie successful regeneration (Griffin et al., 2010, Longo et al., 1984, Ma et al.,

2011 and Ramon y Cajal, 1928); peripheral nerve injury models continue to yield important findings in the field (Ma et al., 2011 and Mantuano et al., 2011). The difference in perception between investigators studying central versus peripheral axonal regeneration can be amusing, as peripheral nerve investigators highlight the incompleteness and limitations in axonal regeneration after injury, whereas spinal cord investigators relish the day that growth of central axons will begin to approach the intrinsic capabilities of peripherally injured axons. As noted early in this monograph, there is also often a gulf in the use of the terms “growth,” “sprouting,” and “regeneration” as applied in the peripheral nerve literature and the CNS. A review of peripheral nerve models is beyond the scope of this Primer and interested readers are referred to recent reviews (Griffin et al., 2010 and Zochodne, 2012).

Posted in Uncategorized | Leave a comment

We found that the vmPFC was modulated by signals related to the s

We found that the vmPFC was modulated by signals related to the subject’s own reward probability in the Other task. Whole-brain analysis during the Other task identified BOLD signals in several brain regions, including the vmPFC (p < 0.05, corrected; Figure 4A), that were significantly modulated by the subject's reward probability (for the stimulus chosen by the subject) at the time of decision (Table 1). The subject's reward probability is the decision variable closest to their choices, as it is the farthest downstream in the hypothesized computational processes for

generating their choices, but it is also based on simulating the other’s decision-making processes, in particular, the simulated-other’s reward probability (Figure S1A). To determine whether the activation of the vmPFC that was significantly modulated by the subject’s reward

probability was compounded by, or possibly rather due to, the simulated-other’s Galunisertib reward probability, we conducted two additional whole-brain analyses: when the simulated-other’s reward probability (for the stimulus chosen by the subject) was added to the regression analysis as a potential confounder and when the regressor variable of the subject’s buy PLX3397 probability was first orthogonalized to the simulated-other’s reward probability and then included in the regression analysis together with the simulated-other’s reward probability. In both cases, vmPFC activation remained significantly modulated by the subject’s reward probability (p < 0.05, corrected). These results indicate that at the time of decision during the Other task, vmPFC activation was significantly modulated by the subject's reward probability. For comparison, the significant vmPFC signals related to the sRPE are also shown in Figure 4A. Here, we emphasize that the sRPE was not the subject's own reward prediction error (the difference

between the subject’s own outcome and his/her own reward probability) during the Other task. Indeed, no region was significantly activated by the subject’s own reward prediction error during the Other task. This observation was confirmed by an additional whole-brain analysis that was conducted in the same way as the original analysis, except that we added the regressor variable for the subject’s own reward prediction error and removed the regressors Astemizole for the sRPE and sAPE. Whole-brain analysis during the Control task revealed significant modulation of vmPFC activity (p < 0.05, corrected) by the reward probability (for the stimulus chosen by the subject) at the time of the decision and the reward prediction error at the time of the outcome (Figure 4B; Table 2). These activities remained significant (p < 0.05, corrected) when the following potential confounders were added to the analysis: the reward magnitude of the chosen stimulus with the reward probability and the value and reward probabilities of the chosen stimulus with the reward prediction error.

Posted in Uncategorized | Leave a comment

Of the 49 nuclear receptors, 20 have been reported to display a c

Of the 49 nuclear receptors, 20 have been reported to display a circadian pattern of mRNA expression in the liver, 19

in white adipose tissue, 18 in brown adipose tissue, and seven in muscle (Yang et al., 2006). The receptors that display these circadian patterns include various isoforms of PPAR, REV-ERB, ROR, and TR. Some of these receptors, such as the REV-ERBs and the RORs, are directly involved in the modulation of the core clock circuitry (Figure 2) and may interact with clock components including PER2 (Schmutz et al., 2010) and CRY (Lamia et al., 2011). Other nuclear receptors, including LXR and FXR, can LDK378 either stimulate or repress genes that produce molecular ligands; one example is the regulation of Cyp7a1. This gene encodes for the rate-limiting enzyme that converts cholesterol to bile acids ( Peet et al., 1998), possibly affecting the intracellular levels of sterol compounds that suppress the transactivational activities of the core clock factors RORα and RORγ in the liver. Fatty acids and their intermediates are natural ligands for PPARs. PPARs regulate adipocytes and insulin sensitivity (PPARγ), modulate the fatty acid oxidation system in mitochondria (PPARα), and regulate cell proliferation, differentiation, and migration in wound healing and inflammatory processes (PPARδ). The isoforms PPARα and PPARγ

find more have been shown to interact (directly or indirectly) with PER2 (Grimaldi et al., 2010 and Schmutz et al., 2010), leading to a time-of-day-dependent modulation

of lipid metabolism (Figure 4) (Grimaldi et al., 2010). In addition, PER3 appears to form a complex with PPARγ, leading to reduced transactivation potential of this nuclear receptor. Accordingly, an increase in adipose tissue and a decrease in muscle tissue were observed in Per3-deficient mice ( Costa et al., 2011). Interestingly, PER2 appears to regulate gamma interferon production in natural killer cells ( Liu et al., 2006), pointing to a potential modulatory function of PER2 for PPARδ. Regulation of glucose homeostasis involves Mephenoxalone glucocorticoids and its receptor. A recent study reported that the clock components of the cryptochrome (Cry) family interact with GR and modulate glucose homeostasis ( Figure 4) ( Lamia et al., 2011). This interaction reduces GR activation potential for the expression of the phosphoenolpyruvate caboxykinase 1 gene (Pck1)—a gene that encodes the rate-limiting enzyme in gluconeogenesis (PEPCK). Accordingly, Cry-deficient cells increased Pck1 expression in response to dexamethason (a synthetic glucocorticoid). In contrast the NF-κB signaling pathway, through which glucocorticoids modulate inflammation, was not affected. This indicates a separation of CRY function in the gluconeogenic and inflammatory pathways of glucocorticoid action ( Lamia et al., 2011). Therefore, modulation of CRY levels may be a potential therapeutic strategy to reduce the side-effects of glucocorticoids on metabolism (i.e.

Posted in Uncategorized | Leave a comment

05) were determined by one-way ANOVA with a Newman-Keuls test or

05) were determined by one-way ANOVA with a Newman-Keuls test or Student’s t test. All measurements were made at room temperature. Introduction of plasmid DNA into the neuroepithelial cells of mouse embryonic neocortex in utero was performed as described elsewhere (Tabata and Nakajima, 2001), with

minor modifications. In brief, the uterine horns were exposed at E14.5, and ∼1 μl DNA solution (0.2–5 μg/μl of each plasmid, depending on the construct) was injected into the lateral ventricle of each littermate. Embryos were then electroporated with an electroporator CUY21EDIT (BEX, 0.5 cm puddle type electrode, 33–35 V, 50 ms duration, four to eight pulses). After electroporation, the uterine horns were returned to the abdominal AT13387 clinical trial cavity to allow the embryos to continue development. For Leu incorporation (Figure 6D), the embryos were harvested 4 days after electroporation, and the brains were then subjected to the imaging analysis. For Cmn incorporation (Figures 6E–6H), the uterine horns were exposed again at E16.5, and Cmn (500 mM, 2–5 μl) was injected to the electroporated side or both sides of the lateral ventricle. The uterine horns were placed

back into the abdominal cavity again. Twelve to forty-eight hours after Cmn injection, the embryos were harvested, and the brains were then subjected to the imaging analysis or electrophysiology as described later. For imaging analysis, the brains were fixed with 4% paraformaldehyde in PBS at 4°C for 2–4 hr. After equilibration with 30% (w/v) sucrose in PBS, the fixed brains were embedded in optimal cutting temperature compound (Sakura) and frozen. Coronal sections (10 μm thick) were prepared by cutting the frozen brains with a cryostat CM3050S (Leica), and the fluorescence of GFP and mCherry was detected using microscopies.

DAPI (Sigma) was used to counterstain nuclei. After in utero electroporation and Cmn delivery, E17.5–E18.5 mice embryos were harvested, and sagittal slices (200 μm) from their Suplatast tosilate neocortices were prepared in ice-cold artificial cerebral spinal fluid (ACSF) (119 mM NaCl, 2.5 mM KCl, 1.3 mM MgCl2, 2.5 mM CaCl2, 1 mM NaH2PO4, 26.2 mM NaHCO3, and 11 mM glucose, pH 7.3) continuously bubbled with 95%/5% O2/CO2. Vibratome slices were warmed to 33°C and incubated for 42 min in ACSF supplemented with 3 mM myo-inositol, 0.4 mM ascorbic acid, and 2 mM sodium pyruvate and then transferred to the recording chamber superfused with ACSF (2 ml/min). Neurons were visualized with a Hamamatsu digital camera (Model C8484) on an Olympus microscope (BX51WI), and whole-cell patch-clamp recordings (Axopatch 200B) were made from neurons in the neocortex. PIRK-expressing neurons were identified by GFP and mCherry fluorescence. The internal solution contained 130 mM potassium gluconate, 4 mM MgCl2, 5 mM HEPES, 1.1 mM EGTA, 3.4 mM Na2ATP, 10 mM sodium creatine phosphate, and 0.1 mM Na3GTP at pH 7.3 with KOH. BaCl2 (0.5 mM) was diluted into ACSF and applied directly on to the slice.

Posted in Uncategorized | Leave a comment

1) [28] This study was conducted in 4 Latin American countries (

1) [28]. This study was conducted in 4 Latin American countries (Mexico, Costa Rica, Guatemala, and Brazil) where OPV was given at ∼2, 4, and 6 months of age. RotaTeq® was given either at the same time as OPV or 2–4 weeks before OPV. After vaccination with the full 3-dose RotaTeq® series, antirotavirus IgA GMC was 47% lower when RotaTeq® was given with OPV (155 U/mL; 95% CI = 126–190) compared to when RotaTeq® was given separately from OPV (293 U/mL; 95% CI = 249–345), with non-overlapping confidence limits. Seroconversion (defined as ≥3-fold rise in serum antirotavirus IgA level) was 5% lower without OPV (93%) than with OPV (98%). Country specific data were not provided. The experience with current and previous rotavirus vaccines provides several important insights relevant for understanding the potential impact of OPV on rotavirus vaccination. The Modulators immune response to the first dose of rotavirus vaccination given concomitantly with the first dose of OPV has almost

always been lower than when vaccine was given without OPV, indicating interference with immune response GSK1349572 nmr to rotavirus vaccination by OPV. However, a review of the older rotavirus vaccines (i.e., not in current use) suggest that OPV’s negative effect on the first dose of rotavirus vaccination has generally been overcome by administration of subsequent rotavirus vaccine doses [20], so that comparable immune responses were seen after the full vaccine series among infants receiving vaccine with or without OPV. The three-doses of RotaTeq® are to be given with the routine EPI schedule, which is at 2, 4, and 6 months in the Americas, but at somewhat younger ages of 6, 10, and 14 weeks in Africa and Asia. For the two-doses of Rotarix™, the WHO recommended that the vaccine should be given with the first two doses of the EPI schedule at 6 and 10 weeks of age [32]. The interference from OPV is likely to have a greater negative impact on efficacy of Linifanib (ABT-869) rotavirus vaccine

during the first EPI visit at 6 weeks of age, when circulating maternal antibodies are also high and are known to also interfere with vaccine take [13], compared to the second and third EPI visits at 10 and 14 weeks of age. Indeed, an earlier immunogenicity study in South Africa demonstrated better immune responses after two doses of the monovalent rotavirus vaccine, RIX4144, at 10 and 14 weeks of age compared to 6 and 10 weeks of age [26]. Therefore, more evaluations are needed in Asia and Africa to assess the efficacy of Rotarix™ when administered at the WHO-recommended 6–10 week schedule compared to alternative schedules such as 10–14 or perhaps 3 doses at 6–10–14 weeks of age. The key question is whether the impact of OPV on the immune response to rotavirus vaccines translates to a reduced protective efficacy, as measured immune responses to rotavirus vaccination do not necessarily correlate with efficacy.

Posted in Uncategorized | Leave a comment

Setting: Primary care based musculoskeletal service in UK Partic

Setting: Primary care based musculoskeletal service in UK. Participants: Men and women 40 years or older with unilateral shoulder pain with moderate or severe pain intensity on a 3-point scale, and with a non-capsular pattern of restriction. Key exclusion criteria were evidence of other pathological conditions in the shoulder and neck. Randomisation of 232 participants allocated 115 to the selleck inhibitor ‘injection plus exercise’ group and 117 to the ‘exercise only’ group. Interventions: Both groups received standard advice to avoid activities that caused or provoked pain. The physiotherapy program started one week after the subacromial injection or immediately in the exercise only arm. The

training sessions were individually adapted and comprised a selection of six mobilisation techniques and 23 progressive exercises. The patients attended as many sessions as deemed necessary by the treating physiotherapist. In addition, the intervention group received one injection of 20 mg triamcinolone acetonide mixed with 4.5 ml 1% lidocaine (lignocaine) at the midpoint of the acromion, which could be repeated after six weeks in patients with ongoing pain. Outcome measures: The primary outcome was the difference in improvement in the total shoulder pain and disability index (SPADI) at 12 weeks. The secondary outcome measure

was global assessment of selleck screening library change on a 5-point scale. Results: 193 of participants completed the study, 96 in the ‘injection plus exercise’ group and 97 to the ‘exercise only’ group. At Week 12 there was no significant difference between the groups in change in SPADI scores: the mean difference between change in groups was 3.3 (95% CI −0.8 to 7.3). Improvement was significantly greater in the injection plus exercise group at Week 1 (6.6, 95% CI 4.3 to 8.8) and Week 6 (7.4, 95% CI 4.3 to 10.4) for the SPADI, with no differences at Week 24 (−2.3, 95% CI −6.8 to 2.3). For the secondary

outcome a similar pattern was seen, with no significant differences at Weeks 12 and 24. For the secondary outcome a similar pattern was seen, with no significant Ribonucleotide reductase differences at Weeks 12 and 24. Conclusion: In the treatment of patients with subacromial impingement syndrome, injection plus exercise and exercise only are similarly effective at 12 weeks. This trial investigated whether reduced pain from a corticosteroid injection and lidocaine Modulators before starting an exercise therapy program would result in better outcome than exercise therapy only. Hence one cannot know whether it was the lidocaine or the steroid injection that gave pain relief. With this in mind, the title is somewhat misleading. The study is well conducted. The authors have performed Rasch transformation of the main outcome instrument, SPADI. As far as we know this has previously been applied only for the SPADI disability subscale (Cook et al 2001). The applied interventions are pertinent for this patient group (Green et al 2006).

Posted in Uncategorized | Leave a comment

, 2013 and Panter et al , 2011) All analyses were conducted in S

, 2013 and Panter et al., 2011). All analyses were conducted in Stata 11.1. Differences in baseline characteristics between participants with and without follow-up data were tested using t tests, χ2 tests or Mann–Whitney U tests. One-way analysis of variance was used to test for differences between change in usual mode(s) and in time spent walking or cycling. Associations between potential predictors and all outcomes were assessed using logistic regression models, initially adjusted for age and sex. Route characteristics were matched to the behaviour of interest; thus walking

models included pleasantness and convenience of routes for walking and convenience of public transport, while cycling models included convenience of routes for cycling. All variables significantly associated at p < 0.25 (in the case of categorical variables, p < 0.25 for heterogeneity CHIR-99021 chemical structure between groups) ( Hosmer and Lemeshow, 1989) were carried forward into multivariable regression models. No adjustment check details was made for clustering by workplace, as preliminary multilevel models suggested no evidence of this. Relocation can alter the length of a commute or the route taken. As a sensitivity analysis, we identified participants who reported different home

or work postcodes at t1 and t2 corresponding to different locations. Excluding these movers (n = 155) from analysis made no substantial difference

to the direction or size of associations, hence the results presented include these participants. Of the 1164 participants who returned questionnaires at t1, 704 (60.5%) completed questionnaires at t2 and 655 too provided information on commuting at both t1 and t2 and were included in this analysis (Table 2). Those included were more likely to be older (mean age of 43.6 years versus 40.5 years, p = 0.01) and to own their own home (75.1% versus 71.8%, p = 0.01) than those who did not participate at t2. There were no significant differences in gender, inhibitors educational qualifications, weight status, car ownership or time spent walking or cycling at baseline. Changes in time spent walking and cycling were symmetrically distributed. Many participants had change values of 0 min/week, reflecting either: (i) no walking (or cycling) at t1 and t2 or (ii) exactly the same number of trips and average duration of walking (or cycling) per trip at t1 and t2. Mean change values were relatively small (walking: + 3.0 min/week, s.d. = 66.7, p = 0.24; cycling: − 5.3 min/week, s.d. = 74.7, p = 0.07). Those who reported more time walking or cycling on the journey to work at t1 tended to report less at t2 ( Fig. 1).

Posted in Uncategorized | Leave a comment